Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
L. Silvia Muñoz-Price, Laurent Poirel, Robert A. Bonomo, Mitchell J. Schwaber, George L. Daikos, Martin Cormican, Giuseppe Cornaglia, Javier Garau, Marek Gniadkowski, Mary K. Hayden, Kanimozhi Kumarasamy, David M. Livermore, Juan José Maya, Patrice Nordmann, Jean B. Patel, David L. Paterson, Johann Pitout, María Virginia Villegas, Hui Wang, Neil Woodford, John P. Quinn
The Lancet Infectious Diseases, 2013
Abstract
An abstract is not available for this record. Please visit the publisher website for more details.
- Colistin Combined With Tigecycline: A Promising Alternative Strategy to Combat Escherichia coli Harboring blaNDM–5 and mcr-1 2020
- Molecular identification of tigecycline- and colistin-resistant carbapenemase-producing Acinetobacter baumannii from a Greek hospital from 2011 to 2013 2015
- In vitro Synergistic Activity of Antimicrobial Combinations Against blaKPC and blaNDM-Producing Enterobacterales With blaIMP or mcr Genes 2020
- Hyperbaric oxygen suppresses growth of Klebsiella pneumoniae and enhances effect of tigecycline in vitro 2017
- Synergistic Activities of Colistin with Tigecycline Combination Against Clinical Isolates of Carbapenem-resistant Acinetobacter baumannii 2019
- Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. 2009
- Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011 2012
- Carbapenem non-susceptible Klebsiella pneumoniae from Micronet network hospitals, Italy, 2009 to 2012 2012
- Emergence and outbreak of carbapenemase-producing KPC-3 Klebsiella pneumoniae in Spain, September 2009 to February 2010: control measures 2012
- First identification of class A carbapenemase-producing Klebsiella pneumoniae in the Republic of Ireland 2009